| Fact Table | |
|---|---|
| Formula | C6H9N3O3 |
| License | FDA approved (MetroCream NDA 020531; marketed from 1995); Health Canada DIN 02226839, cancelled post-market in Canada on 2017-08-01 |
| Bioavailability | Topical absolute bioavailability not established; systemic blood levels are significantly lower after topical use than after oral administration |
| Legal status | Prescription only (Rx only; Prescription in Canada) |
| Chemical Name | 2-methyl-5-nitro-1H-imidazole-1-ethanol; 2-(2-methyl-5-nitroimidazol-1-yl)ethanol |
| Elimination half-life | Approximately 8 hours for systemically absorbed metronidazole |
| Dosage (Strength) | 0.75% topical cream; 7.5 mg metronidazole per gram; apply a thin layer to affected areas twice daily, morning and evening, after washing |
| Pregnancy | Pregnancy Category B in older labeling; no adequate well-controlled studies in pregnant women; use only if clearly needed |
| Brands | MetroCream; MetroGel; MetroLotion; Noritate; Rozex; generic metronidazole topical cream/gel/lotion |
| Protein binding | Less than 20% for circulating metronidazole |
| PubChem CID | 4173 |
| MedlinePlus | a682244 |
| ChEBI | 6909 |
| ATC code | D06BX01; A01AB17; G01AF01; J01XD01; P01AB01 |
| DrugBank | DB00916 |
| KEGG | D00409 |
| Routes of administration | Topical cutaneous application; for external skin use only, not ophthalmic, oral or vaginal use |
MetroCream (metronidazole 0.75%) is a prescription skin cream used to treat symptoms of rosacea. Rosacea is a long-term skin condition that often affects the center of the face, causing redness and acne-like bumps. Metronidazole belongs to a group of medicines called nitroimidazoles and is believed to help reduce skin inflammation. MetroCream is a moisturizing cream applied directly to the skin and is prescribed for adults.
Use MetroCream only on the skin. Apply a thin layer to the affected areas of your face twice a day, morning and evening, after washing with a mild cleanser and patting dry. Rub it in gently, keep it away from your eyes, and use cosmetics only after applying it. Improvement may take several weeks, so use it for as long as your healthcare provider recommends and do not apply it more often or to unaffected areas.
The active ingredient in MetroCream is metronidazole. The inactive ingredients may include benzyl alcohol, emulsifying wax, glycerin, isopropyl palmitate, purified water, sorbitol solution, and lactic acid and/or sodium hydroxide to adjust pH.
Before using this medication, you may want to consult a healthcare provider about the following:
MetroCream is for use on the skin only. It is not for use in the eyes, mouth, nose, or vagina. Contact with the eyes can cause tearing or irritation, so be careful when applying it near the eye area.
If local irritation develops, such as burning, stinging, redness, or worsening of rosacea, your healthcare provider may recommend using MetroCream less often or stopping treatment.
Use MetroCream with care if you have a history of blood disorders (blood dyscrasias), as metronidazole belongs to the nitroimidazole class of medications.
Oral metronidazole has been reported to increase the blood-thinning effect of warfarin and similar anticoagulants, which can prolong prothrombin time. The effect of topical metronidazole on blood clotting is not known.
Avoid applying other medicated or harsh skin products to the same area unless your healthcare provider says it’s okay. Combining topical treatments can increase the chance of irritation.
MetroCream should be used during pregnancy only if clearly needed. Metronidazole crosses the placenta, so any use during pregnancy should be reviewed with a healthcare provider.
When taken by mouth, metronidazole is passed into breast milk. Skin levels from topical use are much lower than from oral use, but talk to your provider about whether to keep using MetroCream or pause breastfeeding.
Safety and effectiveness in children have not been established. Keep the tube out of reach of children.
Avoid taking or using this medication if any of the following apply:
Common side effects of MetroCream include:
Stop using MetroCream and get medical help if you develop signs of a serious allergic reaction, such as swelling of the face, lips, tongue, or throat, trouble breathing, hives, or a widespread rash.
Tell your healthcare provider if skin irritation is severe or doesn’t go away, if rosacea symptoms get worse during treatment, or if you notice any persistent numbness or tingling.
If the cream gets in the eyes by accident, rinse the eyes with plenty of water and contact a healthcare provider if irritation continues.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (e.g., different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.